Novel PLGA-based nanoparticles for the oral delivery of insulin

BACKGROUND: Insulin is the drug therapy for patients with insulin-dependent diabetes mellitus. A number of attempts have been made in the past to overcome the problems associated with the oral delivery of insulin, but with little success. Orally administered insulin has encountered with many difficu...

Descripción completa

Detalles Bibliográficos
Autores principales: Malathi, Sampath, Nandhakumar, Perumal, Pandiyan, Velayudham, Webster, Thomas J, Balasubramanian, Sengottuvelan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383223/
https://www.ncbi.nlm.nih.gov/pubmed/25848248
http://dx.doi.org/10.2147/IJN.S67947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383223/
https://www.ncbi.nlm.nih.gov/pubmed/25848248
http://dx.doi.org/10.2147/IJN.S67947

Ejemplares similares